Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disease which is still poorly understood. The drugs currently used against AD, mainly acetylcholinesterase inhibitors (AChEI), are considered clinically insufficient and are responsible for deleterious side effects. AChE is, ho...

Full description

Bibliographic Details

Published in:	Molecules
Main Authors:	François-Xavier Toublet, Cédric Lecoutey, Julien Lalut, Bérénice Hatat, Audrey Davis, Marc Since, Sophie Corvaisier, Thomas Freret, Jana Sopkova de Oliveira Santos, Sylvie Claeysen, Michel Boulouard, Patrick Dallemagne, Christophe Rochais
Format:	Article
Language:	English
Published:	MDPI AG 2019-07-01
Subjects:	Alzheimer’s disease prodrug acetylcholinesterase 5-HT<sub>4</sub> receptors MTDL
Online Access:	https://www.mdpi.com/1420-3049/24/15/2786